No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Telli Health Announces Verizon Certification, Becomes 1st Medical IoT Device Company to Operate on Their Cellular Network

All Telli Health Devices Can Now Use Verizon Cellular Network, Further Boosting Reliability, Accessibility, and Ease of Use for Patients Everywhere

Editor: What To Know

  • Also observed were increased patient satisfaction, a 50% reduction in patient churn due to accuracy, consistency, and reliability of data transmission using Telli Health devices, and an overall 30% improvement in daily compliance and successful transmissions in which providers received substantially more patient readings.
  • I am very pleased that we have partnered with Verizon to deliver value-based in-home healthcare to more people than ever before, securing Telli Health as the premier destination for reliable, accurate, accessible, and easy-to-use connected care medical devices.
  • Telli Health’s devices use SIM technology that connects to all major cellular carriers in the United States, including AT&T and T-Mobile/Sprint, in addition to Verizon.

Telli Health today announced that it has been certified by Verizon, allowing all of its devices to operate on Verizon, America’s largest and most reliable cellular network. With Verizon’s vast cellular footprint, patients can take a reading from anywhere and know it will be sent instantly to their provider. Telli Health’s connected care devices are the first and only Verizon-certified devices in the United States.

The remote patient monitoring (RPM) industry has long suffered from deficient reliability in transmitting patient readings, as well as the ability to take readings from anywhere. Being Verizon certified will improve this, and for healthcare providers and RPM companies, this means increased patient adherence—a primary goal for both.

Telli Health’s devices use SIM technology that connects to all major cellular carriers in the United States, including AT&T and T-Mobile/Sprint, in addition to Verizon. Globally, coverage includes over 650 cellular carriers in 191 countries.

Jeff Bartzen, Sales Executive at Telli Health, commented, “Our competitors typically use Bluetooth and antiquated third-party technology for their remote care medical devices. This presents problems ranging from connectivity issues to requiring cell phones and difficult pairing for an aging population. Our competitors are only now starting to use cellular-connected devices—which is easier and the way of the future—but they only work on either AT&T or T-Mobile. I am very pleased that we have partnered with Verizon to deliver value-based in-home healthcare to more people than ever before, securing Telli Health as the premier destination for reliable, accurate, accessible, and easy-to-use connected care medical devices. Physicians can trust 4G cellular technology as a tremendous improvement over current devices plagued by connectivity issues and unreliability.”

According to a Telli Health case study with one of the industry’s leading RPM providers, from 2018 through 2020, options for cellular-connection blood pressure and blood glucose devices were very limited despite demand. From high rates of data transmission failures to issues related to accuracy and ease of use, the devices in the marketplace were not up to industry standards. Telli Health entered in 2021, offering 4G cellular-enabled devices that directly addressed these specific issues. Telli Health blood pressure monitors and blood glucose meters consistently delivered accurate and reliable readings. The RPM company reported on average a 10 mmHg reduction in both systolic and diastolic blood pressures, with some patients seeing as much as 30 mmHg reductions. Also observed were increased patient satisfaction, a 50% reduction in patient churn due to accuracy, consistency, and reliability of data transmission using Telli Health devices, and an overall 30% improvement in daily compliance and successful transmissions in which providers received substantially more patient readings. Now being Verizon certified, Telli Health looks forward to expanding these successes with the world’s first touchless 4G Thermometer, 4G Weight Scale (December 2021), and the world’s first 4G Pulse Oximeter (December 2021).

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy